These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

90 related articles for article (PubMed ID: 4140824)

  • 1. [Epidemiology of post transfusion hepatitis].
    Müller S; Obretinow E
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1974; 101(5):842-6. PubMed ID: 4140824
    [No Abstract]   [Full Text] [Related]  

  • 2. [Results of a 5 year prospective study on hepatitis after mass transfusions].
    Lehmann H; Schlaak M
    Verh Dtsch Ges Inn Med; 1976; 82 Pt 1():397-9. PubMed ID: 1029221
    [No Abstract]   [Full Text] [Related]  

  • 3. [The problem of transfusion hepatitis. Results and interpretation of transaminase testing in the blood bank services].
    Scheffler WJ; Peschel G; Tänzer SE; Roewer J; Müller S
    Folia Haematol Int Mag Klin Morphol Blutforsch; 1968; 89(3):322-36. PubMed ID: 4176082
    [No Abstract]   [Full Text] [Related]  

  • 4. Australia antigen and post transfusion hepatitis.
    Berthold H; Kleine N; Büttner G; Müller G
    Prog Immunobiol Stand; 1971; 5():63-6. PubMed ID: 4633979
    [No Abstract]   [Full Text] [Related]  

  • 5. [Post-transfusion hepatitis and the diagnosis of infectious hepatitis in donors (a review of the literature and the authors' own data)].
    Gromashevskaia LL; Khersonskaia RIa; Stroganov BV
    Probl Gematol Pereliv Krovi; 1973 Feb; 18(2):40-5. PubMed ID: 4587776
    [No Abstract]   [Full Text] [Related]  

  • 6. The significance of Australia-antibody in blood donors. Study of liver histology in donors and post-transfusion hepatitis in recipients.
    Reinicke V; Poulsen H; Banke O; Dybkjaer E
    Acta Pathol Microbiol Scand B Microbiol Immunol; 1973 Dec; 81(6):753-6. PubMed ID: 4205739
    [No Abstract]   [Full Text] [Related]  

  • 7. A prospective study of posttransfusion hepatitis. The role of Australia Antigen.
    Gocke DJ
    JAMA; 1972 Feb; 219(9):1165-70. PubMed ID: 5066869
    [No Abstract]   [Full Text] [Related]  

  • 8. [Progress in the theory of viral hepatitis B].
    Nasov SD
    Pediatriia; 1979 Apr; (4):62-6. PubMed ID: 377209
    [No Abstract]   [Full Text] [Related]  

  • 9. Post-transfusion hepatitis in a London hospital: results of a two-year prospective study. A report to the M.R.C. Blood Transfusion Research Committee by the Medical Research Council Working Party on Post-Transfusion Hepatitis.
    J Hyg (Lond); 1974 Oct; 73(2):173-88. PubMed ID: 4370614
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Australia antigen and transfusion hepatitis. A prospective study on the frequency and prevention of transfusion hepatitis].
    Berthold H; Kleine N; Müller G
    Zentralbl Bakteriol Orig A; 1972 May; 220(1):230-4. PubMed ID: 4145571
    [No Abstract]   [Full Text] [Related]  

  • 11. Comparison of Hepa-Gent and hepatitis associated antigen as determinants of liver disease.
    Hantman DI; Raymond J; Ritman SG; Gitnick GL
    Am J Med Technol; 1973 Mar; 39(3):90-3. PubMed ID: 4633789
    [No Abstract]   [Full Text] [Related]  

  • 12. [Decrease of transfusion hepatitis following introduction of transaminases and Australia (SH)-antigen determination in blood donors].
    Arndt HJ; Frese R; Nachtwey K; Loos W; Kaboth U; Creutzfeldt W
    Dtsch Med Wochenschr; 1971 Aug; 96(34):1371-2. PubMed ID: 4998053
    [No Abstract]   [Full Text] [Related]  

  • 13. Post-transfusion hepatits following the use of prothrombin complex concentrates.
    Roberts HR; Blatt PM
    Thromb Diath Haemorrh; 1975 Jun; 33(3):610-6. PubMed ID: 1154316
    [No Abstract]   [Full Text] [Related]  

  • 14. [The risk of hepatitis when using blood and blood products].
    Espmark A
    Lakartidningen; 1972 Dec; 69():Suppl 4:72-5. PubMed ID: 4656853
    [No Abstract]   [Full Text] [Related]  

  • 15. Technical aspects and results of the determination of hepatitis associated antigen (HAA) and antibody.
    Brummelhuis HG
    Vox Sang; 1970; 19(3):228-33. PubMed ID: 4993776
    [No Abstract]   [Full Text] [Related]  

  • 16. [Does a "hepatitis C" besides hepatitis B play an important part in blood transfusion disorders?].
    Frösner G
    Internist (Berl); 1976 May; 17(5):256-7. PubMed ID: 58848
    [No Abstract]   [Full Text] [Related]  

  • 17. Limitations of solid-phase radioimmunoassay for hb ag in reducing frequency of post-transfusion hepatitis.
    Hollinger FB; Aach RD; Gitnick GL; Roche JK; Melnick JL
    N Engl J Med; 1973 Aug; 289(8):385-91. PubMed ID: 4719826
    [No Abstract]   [Full Text] [Related]  

  • 18. Hepatitis virus B infection in an alcoholic with cirrhosis.
    Heit H; Dobbins WO
    Med Ann Dist Columbia; 1973 Jul; 42(7):331-3. PubMed ID: 4516550
    [No Abstract]   [Full Text] [Related]  

  • 19. [Hepatitis following blood transfusions].
    Busch H; Roos D; Creutzfeldt W
    Dtsch Med Wochenschr; 1971 Oct; 96(43):1694-6. PubMed ID: 5099201
    [No Abstract]   [Full Text] [Related]  

  • 20. Control of post-transfusion hepatitis by donor selection and case investigation.
    Taswell HF; Shorter R; Maxwell NG
    Mayo Clin Proc; 1972 Feb; 47(2):98-100. PubMed ID: 5010729
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 5.